TET2 and chronic myelomonocytic leukemia: Moran-Crusio et al. [74] observed that Tet2−/− mice developed splenomegaly at 20 weeks of age, showing phenotypes similar to those observed in human CMML patients with mutant TET2. The data from the different mouse models led to similar observations.